Intracerebral hemorrhage

Emergency Medicine Clinics of North America

Volumn 20, Issue 3, 2002, Pages 631-655

  Panagos, Peter D ^a,b   Jauch, Edward C ^a,b   Broderick, Joseph P ^b,c  

^a UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

^b Greater Cincinnati Northern Kentucky Stroke Team   (United States)

^c UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMINOCAPROIC ACID; ANTIHYPERTENSIVE AGENT; CORTICOSTEROID; DOPAMINE; ENALAPRIL; ENALAPRIL MALEATE; ESMOLOL; ETOMIDATE; FRESH FROZEN PLASMA; FUROSEMIDE; HEPARIN; HYDRALAZINE; LABETALOL; LIDOCAINE; LOOP DIURETIC AGENT; LORAZEPAM; MANNITOL; MIDAZOLAM; MUSCLE RELAXANT AGENT; NITROPRUSSIDE SODIUM; NORADRENALIN; OSMOTIC AGENT; PANCURONIUM; PHENYTOIN; PROTAMINE SULFATE; STREPTOKINASE; UNINDEXED DRUG; VECURONIUM; VITAMIN K GROUP; WARFARIN;

ALCOHOL CONSUMPTION; ANTICOAGULANT THERAPY; ANTIHYPERTENSIVE THERAPY; BRAIN HEMORRHAGE; BRAIN HERNIA; BRAIN REGION; CEREBROVASCULAR ACCIDENT; CLINICAL FEATURE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONGENITAL BLOOD VESSEL MALFORMATION; DEMOGRAPHY; DISEASE COURSE; DRUG ABUSE; DRUG CONTRAINDICATION; EMERGENCY TREATMENT; FIBRINOLYTIC THERAPY; HEART INFARCTION; HUMAN; HYDROCEPHALUS; HYPERTENSION; HYPOCHOLESTEROLEMIA; HYPOTENSION; INTRACRANIAL HYPERTENSION; NEUROSURGERY; PATHOPHYSIOLOGY; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROGNOSIS; RACE DIFFERENCE; REVIEW; RISK FACTOR; SEIZURE; STROKE; VASCULAR AMYLOIDOSIS;

EID: 0036696938     PISSN: 07338627     EISSN: 07338627     Source Type: Journal    
DOI: 10.1016/S0733-8627(02)00015-9     Document Type: Review

References (104)

1. Broderick JP. Intracerebral hemorrhage. In: Gorelick PB, Alter M, editors. Handbook of neuroepidemiology. New York, NY: Marcel Dekker Inc; 1994. p. 141-67.
2. Jauch EC, Elias B. Intracerebral hemorrhage pathophysiology and management. Air Med J 1999;18(2):62-7.
3. Taylor TN, Davis PH, Torner JC. Projected number of strokes by subtype in the year 2050 in the United States [abstract]. Stroke 1998;29:322.
4. Furlan AJ, Whisnant JP, Elveback LR. The declining incidence of primary intracerebral hemorrhage: a population study. Ann Neurol 1979;5:367-73.
5. Qureshi AI, Giles WH, Croft JB. Racial differences in the incidence of intracerebral hemorrhage: effect of blood pressure and education. Neurology 1999;52:1617-21.
6. Kase CS, Mohr JP, Caplan LR. Intracerebral hemorrhage. Stroke pathophysiology, diagnosis, and management. Boston: Butterworth-Heinemann; 1994, p. 561-612.
7. Broderick JP, Brott TG, Tomsick T, et al. The risk of subarachnoid and intracerebral hemorrhages in blacks as compared with whites. N Engl J Med 1992;326:733-6.
8. Suzuki K, Kutsuzawa T, Takita K, et al. Clinico-epidemiologic study of stroke in Akita, Japan. Stroke 1987;18:402-6.
9. Broderick JP, Brott TG, Kothari R, et al. The Greater Cincinnati-Northern Kentucy Stroke Study: preliminary first-ever and total incidence rates of strokes among blacks. Stroke 1998;29:415-21.
10. Broderick JP, Brott TG, Tomsick T, Miller R, Huster G. Intracerebral hemorrhage is more than twice as common as subarachnoid hemorrhage. J Neurosurg 1993;78:188-91.
11. Broderick JP, Adams HP, Barsan W, et al. Guidelines for the management of spontaneous intracerebral hemorrhage: a statement for healthcare professionals from a special writing group of the Stroke Council. American Heart Association. Stroke 1999;30:905-15.
12. Kiyohara Y, Ueda K, Hasua Y, et al. Incidence and prognosis of subarachnoid hemorrhage in a Japanese rural community. Stroke 1989;20:1150-5.
13. Sarti C, Tuomilehto J, Salomaa V, et al. Epidemiology of subarachnoid hemorrhage in Finland from 1983 to 1985. Stroke 1991;22:848-53.
14. Kagan A, Harris BR, Winkelstein W, et al. Epidemiologic studies of coronary heart disease and stroke in Japanese men living in Japan, Hawaii and California: demographic, physical, dietary and biochemical characteristics. J Chronic Dis 1974;27:345-64.
15. Tanaka H, Ueda Y, Hayashi M, et al. Risk factors for intracerebral hemorrhage and cerebral infarction in a Japanese rural community. Stroke 1982;13:62-73.
16. Anderson CS, Chakera TM, Stewart-Wynne EG, Jamrozik KD. Spectrum of primary intracerebral haemorrhage in Perth, Western Australia, 1989-90: incidence and outcome. J Neurol Neurosurg Psychiatry 1994;57:936-40.
17. Broderick JP. Natural history of primary intracerebral hemorrhage. In: Whisnant JP, editor. Population-based clinical epidemiology of stroke. Oxford, England: Butterworth Heinemann; 1993.
18. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 1991;265:3255-64.
19. Vinters H. Cerebral amyloid angiopathy: a critical review. Stroke 1987;18:311-24.
20. Okazaki H, Whisnant J. Clinical pathology of hypertensive intracranial hemorrhage. In: Mizukami M, Kogure K, Kanaya H, Yamori Y, editors. Hypertensive intracranial hemorrhage. New York: Raven Press; 1983. p. 177-80.
21. Vonsattel JP, Myers RH, Hedley-Whyte ET, et al. Cerebral amyloid angiopathy without and with cerebral hemorrhages: a comparative histological study. Ann Neurol 1991;30:637-49.
22. Masuda J, Tanaka K, Ueda K, et al. Autopsy study of incidence and distribution of cerebral amyloid angiography in Hisayama, Japan [abstract]. Stroke 1988;19:205-10.
23. Greenberg SM, Vonsattel JPG. Diagnosis of cerebral amyloid angiopathy: sensitivity and specificity of cortical biopsy. Stroke 1997;28:1418-22.
24. Gorelick PB. Alcohol and stroke. Stroke 1987;18:268-71.
25. Klatsky AL, Armstrong MA, Friedman GD. Alcohol use and subsequent cerebrovascular disease hospitalizations. Stroke 1989;20:741-6.
26. Caplan L. General symptoms and signs. In: Kase CS, Caplan LR, editors. Intracerebral hemorrhage. Boston, MA: Butterworth-Heinemann; 1994. p. 31-43.
27. Okumura K, Iseki K, Wakugami K, et al. Low serum cholesterol as a risk factor for hemorrhagic stroke in men: a community-based mass screening in Okinawa, Japan. Japanese Circulation Journal 1999;63:53-8.
28. Iso H, Jacobs DR, Wentworh D, et al. Serum cholesterol levels: a six-year mortality from stroke in 350,977 men screened for the Multiple Risk Factor Intervention Trial. N Engl J Med 1989;320:904-10.
29. Okada H, Horibe H, Ohno Y, et al. A prospective study of cerebrovascular disease in Japanese rural communities, Akabane and Asalu Part I: evaluation of risk factors in the occurrence of cerebral hemorrhage and thrombosis. Stroke 1976;7:599-607.
30. CAST (Chinese Acute Stroke Trial) Collaborative Group. CAST: randomized placebo-controlled trial of early aspirin use in 20,000 patients with acute ischemic stroke. Lancet 1997;49:1641-9.
31. International Stroke Trial Collaborative Group. The International Stroke Trial (IST): a randomized trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischemic stroke. Lancet 1997;349:1569-81.
32. Mohr JP, Caplan LR, Melski JW, et al. The Harvard Cooperative Stroke Registry: a prospective registry. Neurology 1978;28:754-62.
33. The Publications Committee for the Trial of ORG 10172 in Acute Stroke Treatment (TOAST) Investigators. Low molecular weight heparinoid, ORG 10172 (danaparoid), and outcome after acute ischemic stroke: a randomized controlled trial. JAMA 1998; 279:1265-72.
34. Wintzen A, de Jonge H, Loeliger E, et al. The risk of intracerebral hemorrhage during oral anticoagulant treatment: a population study. Ann Neurol 1984;16:553-8.
35. Petty GW, Lennihan L, Mohr JP, et al. Complications of long-term anticoagulation. Ann Neurol 1988;23:570-4.
36. Fogelholm R, Eskola K, Kiminkinen T, Kunnamo I. Anticoagulant treatment as a risk factor for primary intracerebral hemorrhage. J Neurol Neurosurg Psychiatry 1992;55: 1121-4.
37. Franke CL, de Jonge J, van Sweieten JC, et al. Intracranial hematomas during anticoagulant treatment. Stroke 1990;21:726-30.
38. Hart RG, Boop BS, Anderson DC. Oral anticoagulants and intracranial hemorrhage: facts and hypotheses. Stroke 1995;26:1471-7.
39. Radberg J, Olsson JE, Radberg C. Prognostic parameters in spontaneous intracerebral hematomas with special reference to anticoagulant treatment. Stroke 1991;22:571-6.
40. Woo D, Sauerbeck L, Kissela B, et al. Genetic and environmental risk factors for intracerebral hemorrhage. Stroke 2001;32:321.
41. Brass LM, Lichtman JH, Wang Y, Gurwitz JH, Radford MJ, Krumholz HM. Intracranial hemorrhage associated with thrombolytic therapy for elderly patients with acute myocardial infarction: results from the cooperative cardiovascular project. Stroke 2000;31:1802-11.
42. Clark WM, Wissman S, Albers GW, et al. Recombinant tissue-type plasminogen activator (alteplase) for ischemic stroke 3 to 5 hours after symptom onset: the ATLANTIS study: A randomized controlled trial. JAMA 1999;282:2019-26.
43. Hacke W, Kaste M, Fieschi C, et al. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS). JAMA 1995;274:1017-25.
44. Hacke W, Kaste MD, Fieschi C, et al. Randomised double-blind placebo-controlled trial to thrombolytic therapy with intravenous altepase in acute ischemic stroke (ECASS II). Lancet 1998;352:1245-51.
45. The National Institutes of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995;333:1581-7.
46. Kase CS, Furlan AJ, Wechsler LR, et al. Cerebral hemorrhage after intraarterial thrombolysis for ischemic stroke: the PROACT II trial. Neurology 2001;57(9):1603-10.
47. Feldmann E. Intracerebral hemorrhage. Stroke 1991;22:684-91.
48. Ruiz-Sandoval J, Cantu C, et al. Intracerebral hemorrhage in young people. Stroke 1999;30:537-41.
49. Kaku DA, Lowenstein DH. Emergence of recreational drug abuse as a major risk factor for stroke in young adults. Ann Intern Med 1990;113:821-7.
50. Levine SR, Brust JCM, Futrell N, et al. Cerebrovascular complications of the use of the "crack" form of alkaloidal cocaine. N Engl J Med 1990;323:699-704.
51. Peterson PL, Roszler M, Jacobs I, et al. Neurovascular complications of cocaine abuse. J Neuropsych Clin Neurosci 1991;3:143-9.
52. Sloan MA, Kittner SJ, Rigamonti D, et al. Occurrence of stroke associated with use/abuse of drugs. Neurology 1991;141:1358-64.
53. Diringer MN. Intracerebral hemorrhage: pathophysiology and management. Crit Care Med 1993;21(10):1591-603.
54. Gebel JM, Brott TG, Sila CA, et al. Decreased perihematomal edema in thrombolysis-related intracerebral hemorrhage compared with spontaneous intracerebral hemorrhage. Stroke 2000;31:596-600.
55. Lee KR, Kawai N, Kim S, Sagher O, Hoff JT. Mechanisms of edema formation after intracerebral hemorrhage: effects of thrombin on cerebral blood flow, blood-brain barrier permeability, and cell survival in a rat model. J Neurosurg 1997;86:272-8.
56. Diringer MN, Edwards DF, Zazulia AR. Hydrocephalus: a previously unrecognized predictor of poor outcome from supratentorial hemorrhage. Stroke 1998;29:1352-7.
57. Phan TG, Koh M, Vierkant RA, Wijdicks EFM. Hydrocephalus is a determinant of early mortality in putaminal hemorrhage. Stroke 2000;31:2157-62.
58. Broderick JP, Brott TG, Duldner JE, et al. Volume of intracerebral hemorrhage: a powerful and easy-to-use predictor of 30-day mortality. Stroke 1993;24:987-93.
59. Lisk DR, Pasteur W, Rhaodes H, et al. Early presentation of hemispheric intracerebral hemorrhage: prediction of outcome and guidelines for treatment allocation. Neurology 1994;44:133-9.
60. Qureshi AI, Safdar K, Weil J, et al. Predictors of early deterioration and mortality in black Americans with spontaneous intracerebral hemorrhage. Stroke 1995;26: 1764-7.
61. Tuhrim S, Horowitz DR, Sacher M, et al. Validation and comparison of models predicting survival following intracerebral hemorrhage. Crit Care Med 1995;23:950-4.
62. Hemphill JC, Bonovich DC, Besmertis L, et al. The ICH score: a simple, reliable grading scale for intracerebral hemorrhage. Stroke 2001;32:891-7.
63. Broderick JP, Brott TG, Tomsick T, et al. Ultra-early evaluation of intracerebral hemorrhage. J Neurosurg 1990;72:195-9.
64. Brott T, Broderick J, Kothari R, et al. Early hemorrhage growth in patients with intracerebral hemorrhage. Stroke 1997;28:1-5.
65. Andrews BT, Chiles BW, Olsen WL, Pitts LH. The effect of intracerebral hematoma location on the risk of brain-stem compression and on clinical outcome. J Neurosurg 1988;69:518-22.
66. Mayer SA, Sacco RL, Shi T, Mohr JP. Neurologic deterioration in noncomatose patients with supratentorial intracranial hemorrhage. Neurology 1994;44:1379-84.
67. Melo TP, Pinto AN, Ferro JM. Headache in intracerebral hematomas. Neurology 1996;47:494-500.
68. Ropper AH, Gress DR. Computerized tomography and clinical features of large cerebral hemorrhages. Cerebrovasc Dis 1991;1:38-42.
69. Von Kummer R, Meyding-Lamade U, Forsting M, et al. Sensitivity and prognostic value of early CT in occlusion of the middle cerebral artery trunk. Am J Neuroradiol 1994; 15:9-15.
70. Kothari RU, Brott T, Broderick JP, et al. The ABCs of measuring intracerebral hemorrhage volumes. Stroke 1996;27:1304-5.
71. Zhu XL, Chan MSY, Poon WS. Spontaneous intracranial hemorrhage: which patients need diagnostic cerebral angiography? A prospective study of 206 cases and review of the literature. Stroke 1997;28:1406-9.
72. Brott T, Reed RL. Intensive care for the acute stroke patient in the community hospital setting: the first 24 hours. Stroke 1989;20:694-7.
73. Walls RM. Rapid-sequence intubation in head trauma. Ann Emerg Med 1993;22:1008-13.
74. Kuwata N, Kuroda K, Funayama M, et al. Dysautoregulation in patients with hypertensive intracerebral hemorrhage: a SPECT study. Neurosurg Rev 1995;18:237-45.
75. Qureshi AI, Bliwise DL, Bliwise NG, et al. Rate of 24-hour blood pressure decline and mortality after spontaneous intracerebral hemorrhage: a retrospective analysis with a random effects regression model. Crit Care Med 1999;27:480-5.
76. Powers WJ, Adams RE, Yundt KD, et al. Acute pharmacologic hypotension after intracerebral hemorrhage does not change cerebral blood flow [abstract]. Stroke 1999; 30:242.
77. Berger AR, Lipton RB, Lesser ML, Lantos G, Portenoy RK. Early seizures following intracerebral hemorrhage: implications for therapy. Neurology 1988;38:1363-5.
78. Sjoblom L, et al. Management and prognostic features of intracerebral hemorrhage during anticoagulant therapy: a Swedish multicenter study. Stroke 2001;32:2567-74.
79. Gebel JM, Sila CA, Sloan MA, et al. Thrombolysis-related intracranial hemorrhage: a radiographic analysis of 244 cases from the GUSTO-1 trial with clinical correlation. Global utilization of streptokinase and tissue plasminogen activator for occluded coronary arteries. Stroke 1998;29:563-9.
80. Eleff SM, Borel C, Bell WR, et al. Acute management of intracranial hemorrhages in patients receiving thrombolytic therapy: case reports. Neurosurg 1990;26:867-9.
81. Bogousslavsky J, Leclerc JR. Platelet glycoprotein IIb/IIIa antagonists for acute stroke. Neurology 2001;57(5):S53.
82. Blankenship JC, Menapace FJ, Demko SL. Incidence of intra-cranial hemorrhage in trials of glycoprotein IIb/IIIa receptor inhibitor drugs [abstract]. J Am Coll Cardiol 1999; 33(Suppl):S41A.
83. Blankenship JC. Bleeding complications of glycoprotein IIb/IIIa receptor inhibitors. Am Heart J 1999;138(4):5287-96.
84. Juvela S, Heiskanen O, et al. The treatment of spontaneous intracerebral hemorrhage: a prospective randomized trial of surgery and conservative treatment. J Neurosurg 1989; 70:755-8.
85. Kaufman HH. Treatment of deep spontaneous intracerebral hematomas: a review. Stroke 1993;24(Suppl):1101-6.
86. Fayad PB, Awad IA. Surgery for intracerebral hemorrhage. Neurology 1998;51(Suppl 3):S69-73.
87. Fernandes HM, Gregson B, Siddique S, Mendelow AD. Surgery in intracerebral hemorrhage: the uncertainty continues. Stroke 2000;31:2511-6.
88. Gregson BA, Mendelow AD, Fernandes H, et al. Surgery for intracerebral hemorrhage. Stroke 2000;31:791.
89. Zuccarello M, Brott T, Derex L, et al. Early surgical treatment for supratentorial hemorrhage: a randomized feasibility study. Stroke 1999;30:1833-9.
90. Lopez-Yunez AM, Bruno A, Williams LS, et al. Protocol violations in community-based rT-PA stroke treatment are associated with symptomatic intracranial hemorrhage. Stroke 2001;32:12-6.
91. Mayer SA, Lignelli A, Fink ME, et al. Perilesional blood flow and edema formation in acute intracerebral hemorrhage: a SPECT study. Stroke 1998;29:1791-8.
92. Xi G, Wagner KR, et al. Role of blood clot formation on early edema development after experimental intracerebral hemorrhage. Stroke 1998;29:2580-6.
93. Naff NJ, Carhuapoma JR, Williams MA, et al. Treatment of intraventricular hemorrhage with urokinase: effects on 30-day survival. Stroke 2000;31:841-7.
94. Brass L. Stroke teams. In: De Keyser J, et al, editors. Acute stroke: current approaches to management. Washington: Elsevier; 1996. p. 3-6.
95. Counsell C, Bouonyakarnkul S, Dennis M, et al. Primary intracerebral haemorrhage in the Oxfordshire community stroke project, 2: prognosis. Cerebrovasc Dis 1995;5:26-34.
96. Day JC. Population projections of the US by age, sex, race, and Hispanic origin 1945 to 2050. Current Population Reports Publication P 25-1130. Washington, DC: US Bureau of the Census, US Government Printing Office; 1996.
97. Del Zoppo GJ, Higashida RT, Furlan AJ, et al. PROACT: a phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. Stroke 1998;29:4-11.
98. Furlan A, Higashida R, Weschler L, et al. Intra-arterial pro-urokinase for acute ischemic stroke: the PROACT II study: a randomized controlled trial. JAMA 1999;282:2003-11.
99. Giroud M, Creisson E, Fayolle H, et al. Risk factors for primary cerebral hemorrhage: a population-based-study-the stroke registry of Dijon. Neuroepidemiology 1995;14:20-6.
100. Ott KH, Kase CS, Ojemann RG, Mohr JP. Cerebellar hemorrhage: diagnosis and treatment: a Review of 56 Cases. Arch Neurol 1974;31:160-7.
101. Segal AZ, Chiu RI, Eggleston-Sexton PM, et al. Low cholesterol as a risk factor for primary intracerebral hemorrhage: a case-control study. Neuroepidemiology 1999; 18:185-93.
102. Ueda K, Hasuo Y, Kiyohara Y, et al. Intracerebral hemorrhage in a Japanese community, Hisayama: incidence, changing pattern during a long-term follow-up, and related factors. Stroke 1988;19:48-52.
103. Wagner KR, Guohua X, Hua Y, et al. Lobar intracerebral hemorrhage model in pigs: rapid edema development in perihematomal white matter. Stroke 1996;27:490-7.
104. Yano K, Reed DM, MacLean CJ. Serum cholesterol and hemorrhagic stroke in the Honolulu Heart Program. Stroke 1989;20:1460-5.